🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The focus of this study is to test the safety and efficacy of the PCSK9 inh...
Status
Completed
Location
Stanford University
Start Date
2019-05-13
Trial ID
NCT03537742
Treatments Being Tested
The primary objective of the study was to assess the long-term safety and t...
Status
Completed
Location
Multiple Locations
Start Date
2012-02-28
Trial ID
NCT01576484
Treatments Being Tested
Primary Objective: To assess the safety and tolerability of ascending sing...
Status
Completed
Location
Investigational Site Number 156001
Start Date
2016-11-29
Trial ID
NCT02979015
Treatments Being Tested
CAROTID-STABILISE is a phase III, multicentre, randomised, double-blind, pl...
Status
Not Yet Recruiting
Location
Alexandria University, Smouha University Comprehensive Stroke Center
Start Date
2027-07
Trial ID
NCT07586540
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group, mul...
Status
Completed
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT01709500
Treatments Being Tested
The primary objective of the study is to demonstrate the reduction of low-d...
Status
Completed
Location
Regeneron Research Site
Start Date
2017-10-03
Trial ID
NCT03156621
Treatments Being Tested
The main purpose of this study is to evaluate the effect on mental state (k...
Status
Completed
Location
Regeneron Study Site
Start Date
2016-11-02
Trial ID
NCT02957682
Treatments Being Tested
The primary objective of the study is to assess the pharmacodynamic (PD) ef...
Status
Completed
Location
Multiple Locations
Start Date
2012-02-22
Trial ID
NCT01604824
Treatments Being Tested
The purpose of this study is to determine whether the drug alirocumab, whic...
Status
Completed
Location
Grady Memorial Hospital
Start Date
2023-01-04
Trial ID
NCT05469347
Treatments Being Tested
Primary Objective: To evaluate the efficacy of alirocumab administered eve...
Status
Completed
Location
Excel Medical Clinical Trials, LLC-Site Number:8400001
Start Date
2018-05-31
Trial ID
NCT03510884